Skip to main content
Signal8
Adawi Kamal profile photo

Kamal Adawi

CIK: 0001788393

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)0 (0.0%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)2 (100.0%)

Compensation grants

Other (G, F, J, C, D, …)0 (0.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

FATE THERAPEUTICS INC logo
FATE

FATE THERAPEUTICS INC

Officer

Discretionary Trading P&L

Holdings

Transaction History (2 total)

  • FATE THERAPEUTICS INC logo
    FATE

    FATE THERAPEUTICS INC

    Jan 15, 2026
    Award(A)
    Direct
    25K shares-
  • FATE THERAPEUTICS INC logo
    FATE

    FATE THERAPEUTICS INC

    Oct 20, 2025
    Award(A)
    Direct
    75K shares-

1-2 of 2

About Adawi Kamal

Adawi Kamal (SEC CIK 0001788393) files insider reports with the SEC as Chief Financial Officer of FATE THERAPEUTICS INC (FATE).

Signal8 holds 3 ownership filings by Adawi Kamal (1 Form 3, 2 Form 4), filed between Oct 21, 2025 and Jan 16, 2026. Those filings report 2 transactions, from Oct 20, 2025 to Jan 15, 2026. Signal8's Form 4 history starts in Sep 2024.

The business address on Adawi Kamal's filings is in SAN DIEGO, CA.

Recent filings by Adawi Kamal

  • Jan 15, 2026: Grant or award of FATE shares (Form 4, code A).
  • Oct 20, 2025: Grant or award of FATE shares (Form 4, code A).

Other insiders filing for FATE THERAPEUTICS INC (FATE)

How to read Form 4 transaction codes